Key Highlights

  • Revenue was USD 49.0 million versus 56.3 million, with platform subscription Revenue of USD 23.9 million versus 30.9 million.
  • Visits revenue was USD 23.7 million versus 21.2 million, and other revenue was USD 1.4 million versus 4.2 million.
  • The loss from operations was USD 11.7 million versus 29.3 million, and adjusted EBITDA was negative USD 3.6 million.
  • The net loss was USD 11.0 million versus 31.9 million, and the loss per share was USD 0.67 versus 2.00.

Revenue by Line

American Well Corporation (NYSE:AMWL), which operates as Amwell and provides an enterprise platform and software for hybrid digital care, filed its Quarterly Report for the period ended September 30, 2026. Revenue for the third quarter was USD 48,991 thousand, compared with USD 56,286 thousand in the third quarter of 2025.

Platform subscription revenue was USD 23.9 million versus USD 30.9 million. Visits revenue was USD 23.7 million versus USD 21.2 million, and other revenue was USD 1.4 million versus USD 4.2 million.

Analyst estimates were EPS of negative USD 0.78 against reported EPS of negative USD 0.67, and revenue of USD 47.3 million against reported revenue of USD 49.0 million.

Costs and Operating Loss

Research and development expense was USD 9.6 million versus USD 18.6 million, sales and Marketing expense was USD 7.3 million versus USD 9.1 million, and general and administrative expense was USD 15.5 million versus USD 21.7 million.

Total costs and operating expenses were USD 60.6 million versus USD 85.6 million, and the loss from operations was USD 11.7 million versus USD 29.3 million.

Adjusted EBITDA was negative USD 3.6 million versus negative USD 12.7 million. Severance and strategic transformation costs of USD 0.5 million versus USD 3.2 million were among the items adjusted.

Net Loss and Per Share Results

Income tax expense was USD 0.8 million versus USD 1.2 million.

The net loss was USD 11.0 million versus USD 31.9 million. Net Income attributable to the non-controlling interest was USD 0.4 million versus USD 0.5 million, and the net loss attributable to American Well Corporation was USD 11.4 million versus USD 32.4 million. The net loss per share attributable to common stockholders, basic and diluted, was USD 0.67 versus USD 2.00, on 17,059,760 weighted-average shares versus 16,214,711.

For the nine months, the net loss was USD 30.9 million versus USD 69.8 million.

Net cash used in Operating Activities for the nine months was USD 1.9 million versus USD 48.6 million.

Cash and cash equivalents, comprised of Money Market funds, were USD 180.8 million at September 30, 2026, compared with USD 182.3 million at December 31, 2025. The company reported no Debt at either date and an accumulated Deficit of USD 2,093.8 million at September 30, 2026. Management stated that it believes existing cash and cash equivalents are sufficient for Working Capital and Capital Expenditure needs for at least the next 12 months.

Items to Follow

Investors can follow platform subscription revenue, which was USD 23.9 million in the quarter, alongside visits revenue of USD 23.7 million. The filing lists the digital care market, the company's limited number of significant clients and its history of losses among its stated risk factors.

Other items include adjusted EBITDA, which was negative USD 3.6 million, operating cash use of USD 1.9 million for the nine months, and the company's stated progress toward breakeven in cash used in operations.